Dow's Third Quarter Earnings Per Share Decline by 17%, Sales Growth Stalls!
Dow delivered solid financial performance in the third quarter despite macroeconomic challenges and geographies specific to its operations. Based on generally accepted accounting principles (GAAP), the company earned $0.30 per share, while operating EPS came in at $0.47, though slightly lower than $0.48 in the year-ago period and $0.68 in the prior year quarter. This difference was primarily attributable to restructuring and efficiency enhancement costs and expenses related to previously divested businesses, totaling $0.17 per share.
Net sales reached $10.9 billion, up 1 percent year over year, driven by higher sales in the U.S. and Canada, while sales were stable quarter over quarter. The 1% year-on-year increase in sales volume was mainly driven by higher sales volume in the Functional Materials & Coatings operating segment, while the 1% sequential increase in sales volume was driven by higher sales volume in the Packaging & Specialty Plastics and Industrial Intermediates & Infrastructure operating segments.
Local prices were flat year-on-year, with higher prices in the Packaging & Specialty Plastics operating segment offset by lower prices in the Functional Materials & Coatings operating segment. On a month-on-month basis, local prices were down 1%, with all operating segments Posting small declines. The impact of monetary factors on the year-over-year and quarter-on-quarter remains unchanged.
Equity income was $2 million, up $9 million year over year but down $24 million quarter over quarter. GAAP net income was $240m, while operating earnings before interest and tax (EBIT) was $641m, up $15m year on year, mainly driven by higher overall margins in the packaging & Specialty plastics operating segment, although this increase was partially offset by unplanned shutdowns and planned new maintenance activities at the Texas cracking unit. On a quarter-on-quarter basis, operating EBIT decreased by $178 million, mainly due to unplanned downtime of cracking units and lower local prices in the Europe, Middle East, Africa and India (EMEAI) and Asia Pacific regions.
Cash generated from operating activities was $800 million, down $858 million year over year, primarily due to inventory increases to support volume growth and address labor-related supply chain disruptions. On a sequential basis, cash generated from operating activities decreased by $32 million.
In terms of shareholder returns, the company's overall return to shareholders during the quarter was $584 million, including a dividend return of $490 million and stock repurchases of $94 million.
Jim Fitterling, Chairman and Chief Executive Officer of Dow Jones, said the company achieved four consecutive quarters of year-over-year volume growth in the third quarter despite continued macroeconomic weakness and the unplanned shutdown of the Texas cracker. He highlighted the cost advantage of the company's presence in the Americas, which provides the company with a strong competitive position that allows Dow to capture growth in demand. However, the European and Chinese markets have yet to witness a strong recovery, and the regulatory environment in Europe also poses challenges to the industry and value chain. Mr. Fitterling also mentioned that since 2023, the Company has moved aggressively to optimize the global asset layout and announced a strategic review of certain assets in Europe, primarily the polyurethane business, in order to maximize cash flow and make progress on high-return investments, resulting in long-term shareholder value.
Going forward, Mr. Fitterling said the company will continue to operate with rigor, take full advantage of opportunities in areas of strong demand, and leverage its global scale and cost advantages. As the economic cycle continues to improve, companies are well-positioned to deliver higher returns to shareholders. The company's financial strength will continue to support its anti-cyclical growth investments, which are focused on higher-value businesses and geographies, particularly those where demand is resilient and the company has a cost advantage. These investments are expected to deliver base gains of more than $3 billion by 2030.
2026-10-15
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
BASF India to Shut Two Dahej Care Chemicals Plants as Overcapacity Squeezes Margins
-
LANXESS Specialty Additives Earnings Jump 32.8%, but Chemical Demand Recovery Remains Elusive
-
BASF Brings Biomass-Balance Polyols to North America
-
Production Down 6%, Profits Cut by $3.7 Billion: Middle East Conflict Hits ExxonMobil Hard
-
Wanhua Chemical's Hungarian 650,000-ton MDI/TDI Plant to Shut Down for 35-Day Maintenance
-
Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
-
DyStar Becomes a Wholly-Owned Subsidiary of Zhejiang Longsheng Group, Ending Longstanding Shareholder Disputes with a $5 Billion Deal
-
Pfizer Seen Holding Strategic Edge in Bidding Battle for Metsera
-
Novo Nordisk Enters High-Stakes Bidding War with Pfizer for Metsera
-
Pfizer Sues Metsera and Novo Nordisk Over Rival Obesity Drug Strategy
Recommend Reading
-
LB Group Accelerates Overseas Investment: Securing Mines in Western Australia and Building a Plant in Malaysia
-
BASF Prepared to Preserve Evonik Jobs and German Sites Until 2032 in Potential Takeover
-
China-Saudi Gulei RMB 44.8 Billion Petrochemical Project to Start Production Soon
-
Aster Opens Singapore’s Storage and Marine Network to Third Parties
-
Two Major Dye Giants Hike Prices Consecutively: Longsheng Raises Prices by Up to RMB 10,000/Ton, Yabang Increases Some Products by RMB 60,000/Ton
-
January Maleic Anhydride Prices Overall Increased in China
-
Supply Increases in Stages, China’s Acrylonitrile Market Slips Narrowly
-
Under a Triple Game, Polyethylene Operates with a Weak and Fluctuating Trend
-
This Week's Caustic Soda Prices Consolidate (5.18-5.22)
-
Business Society September 28, 2026 DOP Trend Analysis: Strong Rebound with a Bullish Bias
- Hot Searches
- calcium salmon
- tirzepatide peptide 30mg for sale
- ammonium sulphate crystalline
- retatrutide glp-3 for sale
- buy pharmaceutical grade steroids
- na 931 buy online
- kero prices
- polytetramethylene glycol
- anhydrous ammonia for sale
- sulfate manganese
- price of base oil
- anhydrous sodium sulfate price